These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 31835661)
1. Characterization of Nine Compounds Isolated from the Acid Hydrolysate of Wang X; Wei Y; Tian WY; Sakharkar MK; Liu Q; Yang X; Zhou YZ; Mou CL; Cai GL; Yang J Molecules; 2019 Dec; 24(24):. PubMed ID: 31835661 [TBL] [Abstract][Full Text] [Related]
2. Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses. Arodola OA; Soliman ME Drug Des Devel Ther; 2015; 9():6055-65. PubMed ID: 26622167 [TBL] [Abstract][Full Text] [Related]
3. Pentacycloundecane derived hydroxy acid peptides: a new class of irreversible non-scissile ether bridged type isoster as potential HIV-1 wild type C-SA protease inhibitors. Karpoormath R; Sayed Y; Govender P; Govender T; Kruger HG; Soliman MES; Maguire GEM Bioorg Chem; 2012 Feb; 40(1):19-29. PubMed ID: 21982718 [TBL] [Abstract][Full Text] [Related]
4. The inhibition effect of garlic-derived compounds on human immunodeficiency virus type 1 and saquinavir. Gökalp F J Biochem Mol Toxicol; 2018 Nov; 32(11):e22215. PubMed ID: 30194790 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, 2D-NMR and molecular modelling studies of pentacycloundecane lactam-peptides and peptoids as potential HIV-1 wild type C-SA protease inhibitors. Makatini MM; Petzold K; Alves CN; Arvidsson PI; Honarparvar B; Govender P; Govender T; Kruger HG; Sayed Y; JerônimoLameira ; Maguire GE; Soliman ME J Enzyme Inhib Med Chem; 2013 Feb; 28(1):78-88. PubMed ID: 22339087 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of HIV-1 protease inhibitors with morpholine derivatives as P2 ligands in combination with cyclopropyl as P1' ligand. Dou Y; Zhu M; Dong B; Wang JX; Zhang GN; Zhang F; Wang YC Bioorg Med Chem Lett; 2020 Apr; 30(7):127019. PubMed ID: 32057582 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biological Evaluation of 3,9-Dioxatetraasteranes as C Li P; Wang S; Wang H; Yan H Biol Pharm Bull; 2019; 42(2):261-267. PubMed ID: 30713256 [TBL] [Abstract][Full Text] [Related]
9. Interdependence of Inhibitor Recognition in HIV-1 Protease. Paulsen JL; Leidner F; Ragland DA; Kurt Yilmaz N; Schiffer CA J Chem Theory Comput; 2017 May; 13(5):2300-2309. PubMed ID: 28358514 [TBL] [Abstract][Full Text] [Related]
10. NMR and MD studies combined to elucidate inhibitor and water interactions of HIV-1 protease and their modulations with resistance mutations. Ishima R; Kurt Yilmaz N; Schiffer CA J Biomol NMR; 2019 Jul; 73(6-7):365-374. PubMed ID: 31243634 [TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics and ligand docking of a hinge region variant of South African HIV-1 subtype C protease. Zondagh J; Balakrishnan V; Achilonu I; Dirr HW; Sayed Y J Mol Graph Model; 2018 Jun; 82():1-11. PubMed ID: 29625416 [TBL] [Abstract][Full Text] [Related]
12. Active site binding modes of dimeric phloroglucinols for HIV-1 reverse transcriptase, protease and integrase. Gupta P; Kumar R; Garg P; Singh IP Bioorg Med Chem Lett; 2010 Aug; 20(15):4427-31. PubMed ID: 20594846 [TBL] [Abstract][Full Text] [Related]
13. Exploring the flap dynamics of the South African HIV subtype C protease in presence of FDA-approved inhibitors: MD study. Maphumulo SI; Halder AK; Govender T; Maseko S; Maguire GEM; Honarparvar B; Kruger HG Chem Biol Drug Des; 2018 Nov; 92(5):1899-1913. PubMed ID: 30003668 [TBL] [Abstract][Full Text] [Related]
14. Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease. Gupta A; Jamal S; Goyal S; Jain R; Wahi D; Grover A BMC Bioinformatics; 2015; 16 Suppl 19(Suppl 19):S10. PubMed ID: 26695135 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors. Yan J; Huang N; Li S; Yang LM; Xing W; Zheng YT; Hu Y Bioorg Med Chem Lett; 2012 Mar; 22(5):1976-9. PubMed ID: 22306123 [TBL] [Abstract][Full Text] [Related]
16. Identifying the molecular mechanics and binding dynamics characteristics of potent inhibitors to HIV-1 protease. Li D; Liu MS; Ji B; Hwang KC; Huang Y Chem Biol Drug Des; 2012 Sep; 80(3):440-54. PubMed ID: 22621379 [TBL] [Abstract][Full Text] [Related]